New consortium to develop artificial skin and bone tissue implants  

The 3-D-scaffolds consortium aims to make Denmark a leading player in the market for development of artificial skin and bone tissue implants
A new private-public sector consortium, 3-D-scaffolds, has been set up to develop 3D structures for regeneration of skin and bone tissue which could help the millions of people who each year are injured in fires and road accidents. The aim is to make Denmark into a leading international player in this area. The total budget of 3-D-scaffolds is DKK 40 m (USD 7.2 m) over a four year period, of which the Ministry of Science, Technology and Innovation has donated DKK 12.6 m (USD 2.3 m).
Naseem Theilgaard, chemical engineer at the Danish Technological Institute and head of the consortium says: "There is a great need for developing new implants because the current opportunities for treatment of the many people who each year become victims of fire and road accidents, or suffer from the consequences of cancer, are not optimal."
The consortium aims to develop 3D scaffolds, small blocks of synthetic materials, which can be implanted into damaged areas of the body and support the body's own tissue rebuilding process. 3-D-scaffolds will focus on development of skin, cartilage and bone tissue which so closely resembles the body's own tissue that it will not be rejected.
3-D-scaffolds includes the University of Southern Denmark, Odense University Hospital, Danfoss Bionics, Coloplast, Interface Biotech, Novozymes and Bioneer. The news was reported by professional journal Ingeniøren (The Engineer).

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×